Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Peek, G. J
Right arrow Articles by Firmin, R. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peek, G. J
Right arrow Articles by Firmin, R. K
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An in vitro method for comparing biocompatibility of materials for extracorporeal circulation

Giles J Peek

Division of Cardiac Surgery, Department of Surgery, Glenfield Hospital, University of Leicester, University Hospitals of Leicester NHS Trust, Leicester, UK, ycq57{at}dial.pipex.com

Richard Scott

Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK

Hilliary M Killer

Heartlink ECMO Centre, Department of Cardiothoracic Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK

Richard K Firmin

Heartlink ECMO Centre, Department of Cardiothoracic Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK

We measured the response of fresh heparinized human blood to recirculation through circuits made of LVA (Portex Industries, Hythe, Kent, UK), SRT (Rehau UK, Langley, Slough, UK) and Tygon® S-65-HL (Norton Performance Plastics, Corby, Northants, UK), as control.

Circuit construction: 1/2 in. tubing, heat exchanger (Dideco D-720P), Stockert roller pump, just underoccluded, Cincinnati Sub Zero heater, circuit volume of 500 ml. Flow 3.45 l/min, 37°C.

Samples: at 10 min, 1, 2, 4 and 6 h. n= 5 in each group; 2/5 SRT experiments were stopped at 45 and 60 min due to overpressurization.

Results: Baseline activated clotting time (ACT) of 300 s, increasing in all groups as fibrinogen fell to zero with SRT and LVA. Minimum fibrinogen was 1 g/l for Tygon. Absolute thrombocytopenia occurred (SRT and LVA 60 min and Tygon 240 min). International normalized ratio (INR) in both the SRT and LVA circuits increased, but mean increase for Tygon (0.56) was smaller than the other two materials. Plasma free haemoglobin increased in all three materials; the increase was greater in the LVA circuits compared to the control. C5b9 levels increased equally in all groups. Lactoferrin levels rose equally in all groups to a maximum at 150 min. The neutrophil counts fell, mirroring the lactoferrin. The total white cell counts also fell in all groups; in the LVA circuits, the fall was significantly lower than in the control. Rapid disappearance of platelets and fibrinogen from the blood in the SRT and LVA circuits excludes them both from extracorporeal use. Paradoxically, SRT caused the least complement activation of the three materials. This method can be used to compare biocompatibility.

Perfusion, Vol. 17, No. 2, 125-132 (2002)
DOI: 10.1191/0267659102pf546oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?